Bgm (BGM) Other Accumulated Expenses (2019 - 2025)
Bgm's (BGM) quarterly Other Accumulated Expenses came in at $1.3 million in Q3 2025, down 53.4% year-on-year from $2.9 million in Q3 2024, and up 9.93% on a QoQ basis from $1.2 million in Q1 2025.
Bgm (BGM) Other Accumulated Expenses (2019 - 2025) Analysis & Trends
Bgm (BGM) has 7 years of Other Accumulated Expenses data on file, last reported at $1.3 million in Q3 2025.
- On a quarterly basis, Other Accumulated Expenses fell 53.4% year-over-year to $1.3 million in Q3 2025; TTM through Sep 2025 was $1.3 million, a 53.4% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 53.4% from the prior year.
- Other Accumulated Expenses for Q3 2025 stood at $1.3 million, up from $1.2 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for BGM reached as high as $2.9 million in Q3 2024 and fell as low as $5808.0 in Q3 2023.
- Historically, Other Accumulated Expenses has averaged $934255.0 across 5 years, with a median of $663185.5 in 2022.
- Across the five-year window, Other Accumulated Expenses slumped 95.06% in 2023 and surged 48996.52% in 2024, its largest moves.
- Year by year, Other Accumulated Expenses stood at $92972.0 in 2021, then increased by 26.42% to $117534.0 in 2022, then slumped by 95.06% to $5808.0 in 2023, then jumped by 48996.52% to $2.9 million in 2024, then sank by 53.4% to $1.3 million in 2025.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $1.3 million in Q3 2025, $1.2 million in Q1 2025, and $2.9 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Sep 30, 2024 | 2.85 Mn |
| Sep 30, 2023 | 5,808.00 |
| Sep 30, 2022 | 117,534.00 |
| Sep 30, 2021 | 92,972.00 |
| Sep 30, 2020 | 107,348.00 |
| Sep 30, 2019 | 25,227.00 |